BRAIN METASTASES OF GERM CELL TUMORS. THE RUSSIAN CANCER RESEARCH CENTER'S EXPERIENCE

Cover Page

Cite item

Full Text

Abstract

This paper analyzes the experience in treating 20 patients with nonseminomatous germ cell tumors metastasizing to the brain. It presents brain metastasis-associated factors: multiple lung metastases; IGCCCG poor prognosis; and a baseline human chorionic gonadotropin level of > 50000 mIU/ml. The authors have identified a group to be screened for brain metastasis, which includes patients with intermediate/poor prognosis and multiple lung metastases. Long-term survival was achieved in 45 % of patients with baseline brain damage and in 22 % of those with metastases revealed after first-line chemotherapy. The positive prognostic factors associated with long-term survival were a single brain lesion, no neurological symptoms, and achievement of clinical complete personse in the brain.

About the authors

A. A. Tryakin

N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow

Author for correspondence.
Email: atryakin@mail.ru

Department of Clinical Pharmacology and Chemotherapy

Russian Federation

M. Yu. Fedyanin

N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow

Email: atryakin@mail.ru

Department of Clinical Pharmacology and Chemotherapy

Russian Federation

A. A. Bulanov

N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow

Email: atryakin@mail.ru

Department of Clinical Pharmacology and Chemotherapy

Russian Federation

A. Kh. Bekyashev

N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow

Email: atryakin@mail.ru

Department of Neurosurgery

Russian Federation

V. A. Aleshin

N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow

Email: atryakin@mail.ru

Department of Neurosurgery

Russian Federation

Z. P. Mikhina

N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow

Email: atryakin@mail.ru

Department of Radiotherapy

Russian Federation

V. B. Matveev

N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow

Email: atryakin@mail.ru

Department of Urology

Russian Federation

T. I. Zakharova

N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow

Email: atryakin@mail.ru

Department of Pathomorphology

Russian Federation

A. M. Garin

N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow

Email: atryakin@mail.ru

Department of Clinical Pharmacology and Chemotherapy

Russian Federation

S. A. Tyulyandin

N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow

Email: atryakin@mail.ru

Department of Clinical Pharmacology and Chemotherapy

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c)



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77-36986 от  21.07.2009.